Anti-angiogenesis therapies stimulate Teff cells infiltration but this effect may be blunted by concomitant recruitment of immunosuppressive immune cells and by up-regulation, on tumor cell surface, of PDL-1 which in turn inhibits Teff activity [110]. This evidence concerns the gene CD274 and neoplasm.